Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival

Human Immunology

Volumn 70, Issue 8, 2009, Pages 589-594

  Vlad, George ^a   Ho, Eric K ^a   Vasilescu, Elena R ^a   Colovai, Adriana I ^a   Stokes, Michael B ^a   Markowitz, Glen S ^a   D'Agati, Vivette D ^a   Cohen, David J ^a   Ratner, Lloyd E ^a   Suciu Foca, Nicole ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Anti HLA detection; Antibody mediated rejection; Kidney allograft survival

Indexed keywords

ALLOANTIBODY; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CADAVER KIDNEY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; CADAVER; DIAGNOSTIC ERRORS; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MICROSPHERES; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEROLOGIC TESTS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 68049132868     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.04.018     Document Type: Article

References (28)

1. Patel R., and Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280 (1969) 735-739
2. Hardy M., Suciu-Foca N., McKiernan T., Rohowsky C., Cianci J., Jacob J., et al. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts. Transplant Proc 11 (1979) 389-392
3. Akalin E. Posttransplant immunosuppression in highly sensitized patients. Contrib Nephrol 162 (2009) 27-34
4. Singh N., Pirsch J., and Samaniego M. Antibody-mediated rejection: treatment alternatives and outcomes. Transplant Rev (Orlando) 23 (2009) 34-46
5. Jackson A.M., and Zachary A.A. The problem of transplanting the sensitized patient: whose problem is it?. Front Biosci 13 (2008) 1396-1412
6. Jordan S.C., and Pescovitz M.D. Presensitization: the problem and its management. Clin J Am Soc Nephrol 1 (2006) 421-432
7. Zeevi A., Girnita A., and Duquesnoy R. HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res 36 (2006) 255-264
8. Tinckam K.J., and Chandraker A. Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol 1 (2006) 404-414
9. Bradbury B.D., Fissell R.B., Albert J.M., Anthony M.S., Critchlow C.W., Pisoni R.L., et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2 (2007) 89-99
10. Schweitzer E.J., Wiland A., Evans D., Novak M., Connerny I., Norris L., et al. The shrinking renal replacement therapy "break-even" point. Transplantation 66 (1998) 1702-1708
11. Suciu-Foca N., Reed E., D'Agati V.D., Ho E., Cohen D.J., Benvenisty A.I., et al. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 51 (1991) 593-601
12. Suciu-Foca N., Reed E., Marboe C., Harris P., Yu P.X., Sun Y.K., et al. The role of anti-HLA antibodies in heart transplantation. Transplantation 51 (1991) 716-724
13. Vasilescu E.R., Ho E.K., Colovai A.I., Vlad G., Foca-Rodi A., Markowitz G.S., et al. Alloantibodies and the outcome of cadaver kidney allografts. Hum Immunol 67 (2006) 597-604
14. Ho E.K., Vasilescu E.R., Colovai A.I., Stokes M.B., Hallar M., Markowitz G.S., et al. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. Transpl Immunol 20 (2008) 61-67
15. Karpinski M., Rush D., Jeffery J., Exner M., Regele H., Dancea S., et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 12 (2001) 2807-2814
16. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 (2003) 708-714
17. Cox D.R., and Oakes D. Analysis of survival data (1984), Chapman & Hall, London
18. Bristow R.E., Duska L.R., Lambrou N.C., Fishman E.K., O'Neill M.J., Trimble E.L., et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89 (2000) 1532-1540
19. Zachary A.A. Antibody monitoring: a solid approach to predicting clinical outcome. Transplantation 86 (2008) 768
20. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365 (2005) 1570-1576
21. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5 (2005) 2265-2272
22. Stastny P., Zou Y., Fan Y., Qin Z., and Lavingia B. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells. Contrib Nephrol 162 (2009) 99-106
23. Lietz K., John R., Burke E., Schuster M., Rogers T.B., Suciu-Foca N., et al. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease. Circulation 112 (2005) 2468-2476
24. Opelz G. Newsletter: preformed antibodies against HLA class I and II. http://www.ctstransplant.org/public/newsletters/2008/pdf/2008-3.pdf 2008
25. Mohanakumar T., Giedlin M.A., Rhodes Jr. C.L., DuVall C.H., Mendez-Picon G., Kaplan A.M., et al. Relationship of B cell alloantibodies to renal allograft survival. Transplantation 27 (1979) 273-278
26. Salvatierra O Jr, Melzer J, Vincenti F, Amend WJ Jr, Tomlanovich S, Potter D, et al. Transplant Proc1987;19:160-6.
27. Lockard-Marduel A., Gumbert M., Tomlanovich S., Amend W., Vincenti F., Schralla P., et al. Immunologic alterations induced by donor-specific transfusion. Transplant Proc 21 (1989) 1171-1172
28. Jindra P.T., Zhang X., Mulder A., Claas F., Veale J., Jin Y.P., et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 82 (2006) S33-S35